User contributions for Jesus Hernandez
Jump to navigation
Jump to search
28 February 2014
- 17:5417:54, 28 February 2014 diff hist 0 N File:Ticagrelor 12.png No edit summary current
- 17:5317:53, 28 February 2014 diff hist 0 N File:Ticagrelor 11.png No edit summary current
- 17:5217:52, 28 February 2014 diff hist 0 N File:Ticagrelor 10.png No edit summary current
- 17:5117:51, 28 February 2014 diff hist 0 N File:Ticagrelor 09.png No edit summary current
- 17:5017:50, 28 February 2014 diff hist 0 N File:Ticagrelor 08.png No edit summary current
- 17:4917:49, 28 February 2014 diff hist 0 N File:Ticagrelor 07.png No edit summary current
- 17:4817:48, 28 February 2014 diff hist 0 File:Ticagrelor 06.png Jesus Hernandez uploaded a new version of "File:Ticagrelor 06.png" current
- 17:4817:48, 28 February 2014 diff hist 0 N File:Ticagrelor 06.png No edit summary
- 17:4717:47, 28 February 2014 diff hist 0 N File:Ticagrelor 05.png No edit summary current
- 17:4617:46, 28 February 2014 diff hist 0 N File:Ticagrelor 04.png No edit summary current
- 17:4417:44, 28 February 2014 diff hist 0 N File:Ticagrelor 03.png No edit summary current
- 17:3817:38, 28 February 2014 diff hist 0 N File:Ticagrelor 02.png No edit summary current
27 February 2014
- 23:4323:43, 27 February 2014 diff hist +2,333 N Ticagrelor patient counseling information Created page with "__NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==Patient Counseling Information== See FDA-approved patient labeling (Medication Guide) ===Benefits and Risks=== * Tell pat..."
- 23:2723:27, 27 February 2014 diff hist +1,353 N Ticagrelor how supplied storage and handling Created page with "__NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==How Supplied/Storage and Handling== BRILINTA (ticagrelor) 90 mg is supplied as a round, biconvex, yellow, film-coated table..."
- 23:1923:19, 27 February 2014 diff hist +8,569 N Ticagrelor clinical studies Created page with "__NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==Indications and Usage== ===Clinical Studies=== The clinical evidence for the effectiveness of BRILINTA is derived from PLA..."
- 22:3922:39, 27 February 2014 diff hist +54 Ticagrelor clinical pharmacology →Clinical Pharmacology
- 22:3122:31, 27 February 2014 diff hist +24 Ticagrelor clinical pharmacology →Clinical Pharmacology
- 22:2622:26, 27 February 2014 diff hist −37 Ticagrelor indications and usage →1.1 Acute Coronary Syndromes
- 18:1718:17, 27 February 2014 diff hist +2,132 N Ticagrelor nonclinical toxicology Created page with "__NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==Nonclinical Toxicology== ===Carcinogenesis, Mutagenesis, Impairment of Fertility=== <u>Carcinogenesis</u> Ticagrelor was n..."
- 16:5516:55, 27 February 2014 diff hist +6,555 N Ticagrelor clinical pharmacology Created page with "__NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==Clinical Pharmacology== Ticagrelor is a crystalline powder with an aqueous solubility of approximately 10 μg/mL at room te..."
- 16:3816:38, 27 February 2014 diff hist +1,796 N Ticagrelor description Created page with "__NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==Description== BRILINTA contains ticagrelor, a cyclopentyltriazolopyrimidine, inhibitor of platelet activation and aggregati..."
- 16:2516:25, 27 February 2014 diff hist −6 Ticagrelor overdosage →Overdosage
- 16:2416:24, 27 February 2014 diff hist −1 Ticagrelor overdosage →References
- 16:2316:23, 27 February 2014 diff hist +1,349 N Ticagrelor overdosage Created page with "__NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==Overdosage== There is currently no known treatment to reverse the effects of BRILINTA, and ticagrelor is not expected to be..."
- 16:1816:18, 27 February 2014 diff hist +4,339 N Ticagrelor use in specific populations Created page with "__NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==Use in Specific Populations== '''Pregnancy''' Pregnancy Category C: There are no adequate and well-controlled studies of..."
- 16:0316:03, 27 February 2014 diff hist +2,531 N Ticagrelor drug interactions Created page with "__NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==Indications and Usage== ===Drug Interactions=== Ticagrelor is predominantly metabolized by CYP3A4 and to a lesser extent b..."
- 15:4815:48, 27 February 2014 diff hist −5 Ticagrelor adverse reactions →bleeding
- 15:3815:38, 27 February 2014 diff hist +43 Ticagrelor adverse reactions →Adverse Reactions
26 February 2014
- 23:4823:48, 26 February 2014 diff hist −755 Ticagrelor adverse reactions No edit summary
- 23:4523:45, 26 February 2014 diff hist +611 Ticagrelor adverse reactions →Bleeding
- 23:2123:21, 26 February 2014 diff hist +4 Ticagrelor adverse reactions →Dyspnea
- 23:1823:18, 26 February 2014 diff hist −39 Ticagrelor adverse reactions →Dyspnea
- 23:1523:15, 26 February 2014 diff hist +6,913 Ticagrelor adverse reactions No edit summary
- 22:3922:39, 26 February 2014 diff hist +4 Ticagrelor adverse reactions No edit summary
- 22:2722:27, 26 February 2014 diff hist +4,652 N Ticagrelor warnings and precautions Created page with "__NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==Warnings & Precautions== ===General Risk of Bleeding=== Drugs that inhibit platelet function including BRILINTA increase t..."
- 22:1522:15, 26 February 2014 diff hist +1,579 N Ticagrelor contraindications Created page with "__NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==Contraindications== 4.1 History of Intracranial Hemorrhage BRILINTA is contraindicated in patients with a history of int..."
- 21:5121:51, 26 February 2014 diff hist −8 Ticagrelor dosage forms and strengths No edit summary
- 21:4921:49, 26 February 2014 diff hist 0 Ticagrelor dosage forms and strengths →Dosage Forms & Stranghts
- 21:4821:48, 26 February 2014 diff hist +287 Ticagrelor dosage forms and strengths →Dosage Forms & Stranghts
- 21:4321:43, 26 February 2014 diff hist +754 N Ticagrelor dosage forms and strengths Created page with "NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==Dosage Forms & Stranghts== BRILINTA (ticagrelor) 90 mg is supplied as a round, biconvex, yellow, film-coated tablet marked wi..."
- 17:4117:41, 26 February 2014 diff hist 0 File:Ticagrelor01.png Jesus Hernandez uploaded a new version of "File:Ticagrelor01.png" current
- 17:4017:40, 26 February 2014 diff hist −1 Ticagrelor adverse reactions No edit summary
- 17:3917:39, 26 February 2014 diff hist 0 N File:Ticagrelor01.png No edit summary
- 17:3817:38, 26 February 2014 diff hist +41 N Ticagrelor adverse reactions Created page with "{| |thumb|800px |}"
- 17:3217:32, 26 February 2014 diff hist +7 Ticagrelor dosage and administration →Dosage and Administration
- 17:3017:30, 26 February 2014 diff hist +287 Ticagrelor dosage and administration No edit summary
- 17:2717:27, 26 February 2014 diff hist +287 Ticagrelor indications and usage No edit summary
- 17:2617:26, 26 February 2014 diff hist +779 N Ticagrelor dosage and administration Created page with "__NOTOC__ {{Ticagrelor}} {{CMG}}; {{AE}} {{JH}} ==Dosage and Administration== Initiate BRILINTA treatment with a 180 mg (two 90 mg tablets) loading dose and continue treatme..."
11 February 2014
- 19:2119:21, 11 February 2014 diff hist +4 Hepatotoxicity pathophysiology No edit summary
7 February 2014
- 22:4822:48, 7 February 2014 diff hist +318 Hy's law No edit summary